Previous Article | Next Article ![]()
Journal of Virology, April 2000, p. 3011-3019, Vol. 74, No. 7
Center for Vaccine Development, Institute of
Science and Technology for Development, Mahidol University at Salaya,
Nakhonpathom 73170, Thailand,1 and
Division of Vector-Borne Infectious Diseases, National Center
for Infectious Diseases, Centers for Disease Control and Prevention,
U.S. Department of Health and Human Services, Fort Collins,
Colorado 805222
Received 26 July 1999/Accepted 27 December 1999
The genome of a candidate dengue type 2 (DEN-2) vaccine virus,
strain PDK-53, differs from its DEN-2 16681 parent by nine nucleotides.
Using infectious cDNA clones, we constructed 18 recombinant 16681/PDK-53 viruses to analyze four 16681-to-PDK-53 mutations, including 5' noncoding region (5'NC)-57 C-to-T, premembrane (prM)-29 Asp-to-Val (the only mutation that occurs in the structural proteins), nonstructural protein 1 (NS1)-53 Gly-to-Asp, and NS3-250 Glu-to-Val. The viruses were studied for plaque size, growth rate, and temperature sensitivity in LLC-MK2 cells, growth rate in C6/36 cells,
and neurovirulence in newborn mice. All of the viruses replicated to
peak titers of 107.3 PFU/ml or greater in
LLC-MK2 cells. The crippled replication of PDK-53 virus in
C6/36 cells and its attenuation for mice were determined primarily by
the 5'NC-57-T and NS1-53-Asp mutations. The temperature sensitivity of
PDK-53 virus was attributed to the NS1-53-Asp and NS3-250-Val
mutations. The 5'NC-57, NS1-53, and NS3-250 loci all contributed to the
small-plaque phenotype of PDK-53 virus. Reversions at two or three of
these loci in PDK-53 virus were required to reconstitute the phenotypic
characteristics of the parental 16681 virus. The prM-29 locus had
little or no effect on viral phenotype. Sequence analyses showed that
PDK-53 virus is genetically identical to PDK-45 virus. Restriction of the three major genetic determinants of attenuation markers to nonstructural genomic regions makes the PDK-53 virus genotype attractive for the development of chimeric DEN virus vaccine candidates.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Attenuation Markers of a Candidate Dengue Type 2 Vaccine Virus, Strain 16681 (PDK-53), Are Defined by Mutations in the
5' Noncoding Region and Nonstructural Proteins 1 and 3
*
Corresponding author. Mailing address: Arbovirus
Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers
for Disease Control and Prevention, P.O. Box 2087, Fort Collins, CO 80522. Phone: (970) 221-6494. Fax: (970) 221-6476. E-mail:
rmk1{at}cdc.gov.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|